More good news arrived at NYMC last week in the form of an official letter from the Middle States Commission on Higher Education (MSCHE). At its November 17, 2016 meeting, the MSCHE reaffirmed full accreditation of New York Medical College, recognizing NYMC for its progress and commending the College for the quality of its Periodic Review Report and internal review process. The next evaluation visit of the MSCHE is scheduled for 2020-2021.
The MSCHE is recognized by the U.S. Secretary of Education as the entity to conduct accreditation and pre-accreditation activities for institutions of higher education in Delaware, the District of Columbia, Maryland, New Jersey, New York, Pennsylvania, Puerto Rico, and the U.S. Virgin Islands, including distance education and correspondence education programs offered at those institutions. NYMC has been accredited by the MSCHE since 1995.
According to the MSCHE mission, the accreditation process ensures institutional accountability, self-appraisal, improvement and innovation through peer review and the rigorous application of standards within the context of institutional mission. It assures students and the public of the educational quality of higher education. “As an institution we have every reason to be proud of external validations of our educational programs,” said Edward C. Halperin, M.D., M.A., chancellor and chief executive officer.
The MSCHE accreditation process was led by Ben C. Watson, Ph.D., vice dean of the School of Health Sciences and Practice, Matthew A. Pravetz, Ph.D., assistant dean for basic sciences in the School of Medicine and professor of cell biology and anatomy, Charles T. Stier, Ph.D., associate professor of pharmacology and director of the M.S. Program in Pharmacology, and Michael Rogovin, J.D., vice president of operations.